Agonist Interactions with Beta-Adrenergic Receptors Following Chronic Administration of Desipramine or the Atypical Antidepressants, Iprindole and Mianserin

References

• Sugrue M. F. Some effects of chronic antidepressant treatments on rat brain monoaminergic systems. J. Neural. Transmission 1983; 57: 281–295
   PubMed Web of Science ®Google Scholar
• Frazer A., Pandey G, Mendels J., Neeley S., Kane M., Hess M. E. The effect of tri-iodothyronine in combination with imipramine on [3H]-cyclic AMP production in slices of rat cerebral cortex. Neuropharmacology 1974; 13: 1131–1140
   Web of Science ®Google Scholar
• Sugrue M. F. Chronic antidepressant therapy and associated changes in central monoaminergic receptor functioning. Pharmacology and Therapeutics 1983; 21: 1–33
   PubMed Web of Science ®Google Scholar
• Sulser F., Vetulani J., Mobley P. L. Mode of action of antidepressant drugs. Biochem. Pharmacol. 1978; 27: 257–261
   PubMed Web of Science ®Google Scholar
• De Lean A., Stadel J. M., Lefkowitz R. J. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled β-adrenergic receptor. J. Biol. Chem. 1980; 255: 7108–7117
   PubMed Web of Science ®Google Scholar
• Lefkowitz R. J., Stadel J. M., Cerione R. A., Strulovici B., Caron M. G. Structure and function of β-adrenergic receptors: Regulation at the molecular level. Advances in Cyclic Nucleotide and Protein Phosphorylation Research, P. Greengard. Raven Press, New York 1984; Vol. 17: 19–28
   Google Scholar
• Sethy V. H., Harris D. W. Role of beta-adrenergic receptors in the mechanism of action of second-generation antidepressants. Drug Dev. Res. 1982; 2: 403–406
   Web of Science ®Google Scholar
• Ursillo R. C., Wiech N. L., Reisine T. D., Yamamura H. L. Mechanism of action of antidepressants. Psychopharmacology and Biochemistry of Neurotransmitter Receptors, H. I. Yamamura. Elsevier/North Holland, New York 1982; 189–202
   Google Scholar
• Olpe H.-R., Schellenberg A., Steinaann H. W. differential actions of mianserin and iprindole on the sensitivity of cortical neurons to noradrenaline: Effect of chronic treatment. Europ. J. Pharmacol. 1981; 72: 381–385
   PubMed Web of Science ®Google Scholar
• Mishra R., Janowsky A., Sulser F. Action of mianserin and zimelidine on the norepinephrine receptor coupled adenylate cyclase system in brain: Subsensitivity without reduction in β-adrenergic receptor binding. Neuropharmacology 1980; 19: 983–987
   PubMed Web of Science ®Google Scholar
• Janowsky A., Steranka L. R., Gillespie D. D., Sulser F. Role of neuronal signal input in the down-regulation of central noradrenergic receptor function by antidepressant drugs. J. Neurochem. 1982; 39: 290–292
   PubMed Web of Science ®Google Scholar
• Engel G., Hoyer D., Berthold R., Wagner H. (±) [125Iodo]cyanopindolol, a new ligand for β-adrenoceptors: Identification and quantitation of subclasses of β-adrenoceptors in guinea pig. Naunyn-Schmiedeberg's Arch. Pharmacol. 1981; 317: 277–285
   Web of Science ®Google Scholar
• Burgisser E., Hancock A. A., Lefkowitz R., Lean A. Anomalous equilibrium binding properties of high-affinity racemic radioligands. Mol. Pharmacol. 1981; 19: 205–216
   PubMed Web of Science ®Google Scholar
• Hancock A. A. A rapid, economical technique for removing radioactivity from receptor binding assay aqueous wastes. Health Physics 1984; 47: 640–641
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Hancock A. A., DeLean A. L., Lefkowitz R. J. Quantitative resolution of beta-adrenergic receptor subtypes by selective ligand binding: Application of a computerized model fitting technique. Mol. Pharmacol. 1979; 16: 1–9
   PubMed Web of Science ®Google Scholar
• Hancock A. A., Marsh C. L. Distinctions between ligand binding sites for [3H]dopamine and D-2 dopaminergic receptors characterized with [3H]-spiroperidol. Mol. Pharmacol. 1984; 26: 439–451
   PubMed Web of Science ®Google Scholar
• Doyle V. M., Buhler F. R., Burgisser E. Inappropriate correction for radioactive decay in fully iodinated adrenergic radioligands. Europ. J. Pharmacol. 1984; 99: 353–356
   PubMed Web of Science ®Google Scholar
• Kent R. S., DeLean A., Lefkowitz R. J. A quantitative analysis of beta-adrenergic receptor interactions: Resolution of high and low affinity states of the receptor by computer modeling of ligand binding data. Mol. Pharmacol. 1980; 17: 14–23
   PubMed Web of Science ®Google Scholar
• Petrovic S. L., McDonald J. K., Snyder G., Mc Cann S. M. Characterization of β-adrenergic receptors in rat brain and pituitary using a new high affinity ligand, [125I]Iodocyanopindolol. Brain Research 1983; 261: 249–259
   PubMed Web of Science ®Google Scholar
• Hoyer D., Engel G., Berthold R. Binding characteristics of (+)-, (±)- and (−)-[125Iodo]cyanpindolol to guinea pig left ventricle membranes. Naunyn-Schmiedeberg's Arch. Pharmacol. 1982; 318: 319–329
   Google Scholar
• Wiech N. L., Ursillo R. C. Acceleration of desipramine-induced decrease of rat corticocerebral β-adrenergic receptors by yohimbine. Communications in Psychopharmacology 1980; 4: 95–100
   PubMedGoogle Scholar
• Stadel J. M., Strulovici B., Nambi P., Lavin T. N., Briggs M. M., Caron M. G., Lefkowitz R. J. Desensitization of the β-adrenergic receptor of frog erythrocytes. Recovery and characterization of the down-regulated receptors in sequestered vesicles. J. Biol. Chem. 1983; 258: 3032–3038
   PubMed Web of Science ®Google Scholar
• Wiech N. L., Personal communication
   Google Scholar
• Minneman K. P., Dibner M. D., Wolfe B. B., Molinoff P. B. β1- and β2-adrenergic receptors in rat cerebral cortex are independently regulated. Science 1979; 204: 866–868
   PubMed Web of Science ®Google Scholar
• Bryan L. J., Cole J., Donnell S. R., Wanstall J. C. A study designed to explore the hypothesis that beta-1 adrenoceptors are “innervated” receptors and beta-2 adrenoceptors are “hormonal” receptors. J. Pharmacol. Exp. Ther. 1981; 216: 395–400
   PubMed Web of Science ®Google Scholar
• Wolfe B. B., Harden T. K., Sporn J. R., Molinoff P. B. Presynaptic modulation of beta adrenergic receptors in rat cerebral cortex after treatment with antidepressants. J. Pharmacol. Exp. Ther. 1978; 207: 446–457
   PubMed Web of Science ®Google Scholar
• Hancock A. A., Marsh C. L., Unpublished data
   Google Scholar
• O'Donnell J. M., Wolfe B. B., Frazer A. Agonist interactions with beta adrenergic receptors in rat brain. J. Pharmacol. Exp. Therap. 1984; 228: 640–647
   PubMed Web of Science ®Google Scholar
• Sellinger-Barnette M. M., Mendels J., Frazer A. The effect of psychoactive drugs on beta-adrenergic receptor binding sites in rat brain. Neuropharmacol. 1980; 19: 447–454
   PubMed Web of Science ®Google Scholar
• Stadel J. M., Naubi P., Shorr R. G.L., Sawyer D. F., Caron M. G., Lefkowitz R. J. Catecholamine-induced desensitization of turkey erythrocyte adenylate cyclase is associated with phosphorylation of the β-adrenergic receptor. Proc. Natl. Acad. Sci., U.S.A. 1983; 80: 3173–3177
   PubMed Web of Science ®Google Scholar
• Eldridge J. S., Crowther P. Absolute determination of 125I in clinical applications. Nucleonics 1964; 22: 56–59
   Google Scholar